A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Clinical trial NCT04115956 · TERMINATED
Trial details
- NCT number
- NCT04115956
- Sponsor
- Oncopeptides AB
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2022-01-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.